Skip to content

Neurocognitive side effects of drug used in Seizures

A Study of anxiety depression and cognitive side effects of antiepileptic drugs in patients with epilepsy - ANCODE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/083742
Enrollment
200
Registered
2025-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G408- Other epilepsy and recurrent seizures

Interventions

Control Intervention1: NIL: NIL

Sponsors

GGS Medical College and Hospital Faridkot
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients attending Neurology and Psychiatric OPD for the treatment of epilepsy and on medication for at least 3 months Patients who give consent to be part of study Patients of age group more than equal to 12 years old

Exclusion criteria

Exclusion criteria: Any active psychiatric disorder prior to epileptic medication Other chronic neurological diseases like Parkinsons disease or Brain tumours Organic brain syndromes like dementia meningitis encephalitis encephalopathy frontal lobe lesions Severe medical illnesses like cardiac respiratory renal and other medical illnesses that may interfere with the evaluation Intellectual disability Head Injury 7. Patient who did not give consent.

Design outcomes

Primary

MeasureTime frame
To study the anxiety, depression, cognitive side effects of Antiepileptic drugsTimepoint: 18 month

Secondary

MeasureTime frame
N/ATimepoint: N/A

Countries

India

Contacts

Public ContactDr Raj Kumar

GGS Medical College and Hospital Faridkot

sportsdoc.gk@gmail.com8447148710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026